Meiji Seika Achieves Medium-Term Plan Goal Of ¥30B In Generic Sales One Year Early
This article was originally published in PharmAsia News
Executive Summary
Meiji Seika has reach their goal of ¥30 billion ($294 million) in generic drug sales one year earlier than anticipated in their three-year mid-term plan, president Daikichiro Kobayashi explained at a press conference on July 2.